Avrobio NASDAQ IPO

20/8/2018

IPO

Status:

Announced

Date:

20/8/2018

Overview:

Avrobio has raised $115 million with its IPO on NASDAQ.
Ernst & Young acted as financial adviser.

Mihail Georgiev - Data analyst

Jurisdictions:

United States
New York

Deal type:

IPO

Practice area:

Capital markets : Equity

Governing laws:

New York
United States

Industry sector:

Pharmaceuticals and life sciences

Firms:

Goodwin Procter

Party: Avrobio Inc (Issuer)

Lawyers: Joseph Theis Jr, Stuart Cable

Ropes & Gray

Party: Cowen and Company (Lead underwriter)

Party: Morgan Stanley (Lead underwriter)

Party: Wells Fargo Securities (Lead underwriter)

Related deals